Title: Title# Defibrotide improved outcome of monocrotaline induced rat hepatic sinusoidal
obstruction syndrome
Version: 3 Date: 28 Jul 2022
Reviewer's report:
This revision is much better. Still, several typo errors, improper descriptions, and grammatical
errors were present in this manuscripts. This manuscript may require professional editing to
eliminate possible grammatical  errors.
Line 476 typo error
bibrin
Line 513, please, use sentence, instead of symbol description.
Line 607 error,
Each groups?
Line 694/ Line 696/ Line 700
What means “Plasma levels of TNF-# and PAI-1 n different groups”
Do the authors meant “TNF-# and PAI-1 levels I in plasmas from animals in different
experimental groups.
Line 821-823 please, add literature to reference
Line 828-829 This description is inappropriate.
In the past, several drugs have been attempted to treat or prevent HSOS following HSCT.
Line 850-853
The description is improper. None of mechanisms were characterized in that literature “reference
15”. That is kind of pheromonal observation.
Title: Title# Defibrotide improved outcome of monocrotaline induced rat hepatic sinusoidal
obstruction syndrome
Version: 3 Date: 28 Jul 2022
Reviewer's report:
This revision is much better. Still, several typo errors, improper descriptions, and grammatical
errors were present in this manuscripts. This manuscript may require professional editing to
eliminate possible grammatical  errors.
Line 476 typo error
bibrin
Line 513, please, use sentence, instead of symbol description.
Line 607 error,
Each groups?
Line 694/ Line 696/ Line 700
What means “Plasma levels of TNF-# and PAI-1 n different groups”
Do the authors meant “TNF-# and PAI-1 levels I in plasmas from animals in different
experimental groups.
Line 821-823 please, add literature to reference
Line 828-829 This description is inappropriate.
In the past, several drugs have been attempted to treat or prevent HSOS following HSCT.
Line 850-853
The description is improper. None of mechanisms were characterized in that literature “reference
15”. That is kind of pheromonal observation.
Please review this paper.
user
Title: Title# Defibrotide improved outcome of monocrotaline induced rat hepatic sinusoidal
obstruction syndrome
Version: 3 Date: 28 Jul 2022
Reviewer's report:
This revision is much better. Still, several typo errors, improper descriptions, and grammatical
errors were present in this manuscripts. This manuscript may require professional editing to
eliminate possible grammatical  errors.
Line 476 typo error
bibrin
Line 513, please, use sentence, instead of symbol description.
Line 607 error,
Each groups?
Line 694/ Line 696/ Line 700
What means “Plasma levels of TNF-# and PAI-1 n different groups”
Do the authors meant “TNF-# and PAI-1 levels I in plasmas from animals in different
experimental groups.
Line 821-823 please, add literature to reference
Line 828-829 This description is inappropriate.
In the past, several drugs have been attempted to treat or prevent HSOS following HSCT.
Line 850-853
The description is improper. None of mechanisms were characterized in that literature “reference
15”. That is kind of pheromonal observation.
assistant